Phospho-PLB (Ser16) Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca (2+) . Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2.
Synonyms
Cardiac phospholamban; CMD1P; CMH18; PLB; Pln.
Gene ID
5350
Swiss Prot
P26678
Modification Site
Ser166
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Mouse
Target
PLB
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human PLB around the phosphorylation site of S16
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5350
Predicted Cross Reactivity
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
170343 50 µg
CRTH2 (PTGDR2, CD294, CRTH2, CD294 antigen, DP2, DL1R, G-Protein-coupled Receptor 44, G-Protein coupled Receptor 44, HCRTH2, DP2 Prostaglandin Receptor, GPR44, Prostaglandin D2 Receptor 2)
Ask
View Details